A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2721-2731

  Kaina, Bernd ^a   Haas, Simone ^a   Kappes, Holger ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; MELPHALAN; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DIAGNOSIS; DNA DAMAGE; DNA REPLICATION; EMBRYO; GENETIC STABILITY; IONIZING RADIATION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN INDUCTION;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CELL SURVIVAL; CELLS, CULTURED; DNA REPLICATION; FIBROBLASTS; GENES, FOS; MELPHALAN; METHYL METHANESULFONATE; METHYLNITRONITROSOGUANIDINE; METHYLTRANSFERASES; MICE; MICE, KNOCKOUT; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; S PHASE; TIME FACTORS;

EID: 0030802033     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Devary, Y., Gottlieb, R. A., Smeal, T., and Kurin, M. The mammalian ultraviolet response is triggered by activation Src tyrosine kinases. Cell. 71: 1081-1091, 1992.
2. Coso, A. A., Chiariello, M., Yu, J-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. The small GTP-binding proteins Racl and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81: 1137-1146, 1995.
3. Cavigelli, M., Dolfi, F., Claret, F-X., and Karin, M. Induction of c-fos expression , through JNK-mediated TCF/EIk-1 phosphorylation. EMBO J., 14: 5957-5964, 1995.
4. Radler-Pohl, A., Sachsenmaier, C., Gebel, S., Auer, H., Bruder, J. T., Rapp, U., Angel, P., Rahmsdorf, H. J., and Herrlich, P. UV-induced activation of AP-1 involves obligatory extranuclear steps including Rat-1 kinase. EMBO J., 12: 1005-1012, 1993.
5. Lee, W., Mitchell, P., and Tjian, R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49: 741-752, 1987.
6. Devary, Y., Gottlieb, R. A., Lau, L. F., and Karin, M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol., 11: 2804-2811, 1991.
7. Büscher, M., Rahmsdorf, H. J., Litfin, M., Karin, M., and Herrlich, P. Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene, 3: 301-311, 1988.
8. 6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Oncogene, 13: 1927-1935, 1996.
9. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
10. Fritsche, M., Haessler, C. and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
11. Di Leonardo, A., Linke, S. P., Clarkin, K., and Wahl, G. M. DNA damage triggers a prolonged p53-dependenl G, arrest and long-term induction of Cip 1 in normal human fibroblasts. Genes Dev., 8: 25-40-2551, 1994.
12. Barak, Y., Juven, T., Haffner, R., and Oren, M. mdm2 expression is induced by wild-type p53 activity. EMBO J., 12: 461-468, 1993.
13. Kovary, K., and Bravo, R. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol., 11: 4466-4472, 1991.
14. Lord, K. A., Abdollahi, A., Hoffmann-Liebermann, B., and Liebermann, D. A. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol., 13: 841-851, 1993.
15. Jenuwein, T., Müller, D., Curran, T., and Müller, R. Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV. Cell, 41: 629-637, 1985.
16. Smcyne, R. J., Vendrell, M., Hayward, M., Baker, S. J., Miao, G. G., Schilling, K., Robertson, L. M., Curran, T., and Morgan, J. I. Continuous e-fos expression precedes programmed cell death in vovo. Nature (Lond.), 363: 166-169, 1993.
17. Angel, P., Rahmsdorf, H. J., Pöting, A., and Herrlich, P. c-fos mRNA levels in primary human fibroblasts after arrest in various stages of the cell cycle. Cancer Cells, 3: 315-319, 1985.
18. Woloschak, G. E., and Chang-Liu, C. Differential modulation of specific gene expression following high and low-LET radiation. Radiat. Res., 124: 183-187, 1990.
19. Hollander, M. C., and Fornace, A. J. J. Induction of fos RNA by DNA-damaging Agents. Cancer Res., 49: 1687-1692, 1989.
20. Futscher, B. W., and Erickson, L. C. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents. Cancer Res., 50: 62-66, 1990.
21. Herrlich, P., Ponta, H., and Rahmsdorf, H. J. DNA damage-induced gene expression: signal transduction and relation to growth factor signaling. Rev. Physiol. Biochem. Pharmaeol., 119: 187-212, 1992.
22. 6-methylguanine-DNA melhyltransferase in mammalian cells by DNA-damaging treatments. Mol. Cell. Biol., 11: 4660-4668, 1991.
23. Grombacher, T., Mitra, S., and Kaina, B. Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes, Carcinogenesis (Lond.), 17: 2329-2336, 1996.
24. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
25. Haas, S., and Kaina, B. e-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis (Lond.), 5: 985-991, 1995.
26. Schreiber, M., Baumann, B., Cotten, M., Angel, P., and Wagner, E. F. Fos is an essential component of the mammalian UV response. EMBO J., 14: 5338-5349, 1995.
27. Brüsselbach, S., Möhle-Steinlein, U., Wang, Z-Q., Schreiber, M., Lucibello, F. C., Müller, R., and Wagner, E. F. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene, 10: 79-86, 1995.
28. Glatt, H., Piee, A., Pauly, K., Steinbrecher, T., Schrode, R., Oeseh, F., and Seidel, A. Fjord-and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella trphimurium and mammalian cells. Cancer Res., 51: 1659-1667, 1991.
29. Cejna, M., Fritseh, G., Printz, D., Schulte-Hermann, R., and Bursch, W. Kinetics of apoptosis and secondary necrosis in cultured rat thymocytes and S.49 mouse lymphoma and CEM human leukemia cells. Biochem. Cell Biol., 72: 677-685, 1994.
30. Fraker, P. J., King, L. E., Lill-Elghanian, D., and Telford, W. G. Quantification of apoptotic events in pure and heterogenous populations of cells using flow cytometer. Methods Cell Biol., 46: 57-76, 1995.
31. Oberhammer, F., Fritsch, G., Schmied, M., Pavelka, M., Printz, D., Purchio, T., Lassmann, H., and Schulte-Hermann, R. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci., 104: 317-326, 1993.
32. 6-Methylguanine-DNA methyltransferase activity in breast and brain tumors. Int. J. Cancer, 61: 321-326, 1995.
33. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
34. Ibeanu, G., Hartenstein, B., Dunn, W. C., Chang, L. Y., Hofmann, E., Coquerelle, T., Mitra, S., and Kaina, B. Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis (Lond.), 13: 1989-1995, 1992.
35. Tomicic, M., Eschbach, E., and Kaina, B. Expression of yeast but not human apurinic/apyrimidinic endonuclease renders Chinese hamster cells more resistant to DNA damaging agents. Mutat. Res., 383: 155-165, 1997.
36. Prosperi, E., Scovassi, A. I., Stivala, L. A., and Bianchi, L. Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with Cyclin D1 and Cyclin A. Exp. Cell Res., 215: 257-262, 1994.
37. Glatt, H., Gemperlein, I., Setiabudi, F., Platt, K. L., and Oesch, F. Expression of xenobiolic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis, 5: 241-249, 1990.
38. 6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberralions, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines. Environ. Mol. Mutagen., 22: 283-292, 1993.
39. Li, R., Waga, S., Hannon, G. J., Beach, D., and Stillman, B. Differential effects by the p21 cdk inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371: 534-537, 1994.
40. Kaina, B., and Meister, A. On time dependency of frequency and distribution of chromatid aberrations induced by mutagens with delayed effects. J. Theor. Biol., 88: 485-501, 1981.
41. Kihlman, B. A. Caffeine and Chromosomes. Amsterdam: Elsevier Scientific, 1977.
42. Natarajan, A. T., and Zwanenburg, T. S. B. Mechanisms for chromosomal aberrations in mammalian cells. Mutat. Res., 95: 1-6, 1982.
43. Friedberg, E. C., Walker, G. C. and Siede, W. DNA Repair and Mutagenesis. Washington, DC: American Society for Microbiology Press, 1995.
44. Coquerelle, T., Dosch, J., and Kaina, B. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents: a case of imbalanced DNA repair. Mutat. Res, 336: 9-17, 1995.
45. Engelward, B. P., Dreslin, A., Christensen, J., Huszar, D., Kurahara, C., and Samson, L. Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J., 15: 945-952, 1996.
46. Ono, Y., Futura, T., Ohmoto, T., Akiyama, K., and Seki, S. Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat. Res., 315: 55-63, 1994.
47. Hayes, J. D., and Pulford, D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 30: 445-600, 1995.
48. Galloway, S. M. Chromosome aberrations induced in vivo: mechanisms, delayed expression, and intriguing questions. Environ. Mol. Mutagen, 23: 44-53, 1994.
49. Kaina, B., Waller, H., Waller, M., and Rieger, R. The action of N-methyl-N-nitrosourea on non-established human cell lines in vitro. I. Cell cycle inhibition and aberration induction in diploid and Down's fibroblast. Mutat. Res., 43: 387-400, 1977.
50. Kaufmann, W. K., Boyer, J. C., Smith, B. A., and Cordeiro-Stone, M. DNA repair and replication in human fibroblasts treated with 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Biochem. Biophys. Acta, 824: 146-151, 1985.
51. Painter, R. B., and Howard, R. The HeLa DNA-synthesis inhibition lest as a rapid screen for mutagenic carcinogens. Mutat. Res., 92: 427-437, 1982.
52. Heil, J., and Reifferscheid, G. Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test. Carcinogenesis (Lond.), 13: 2389-2394, 1992.
53. Kaina, B. The interrelationship between SCE induction, cell survival, mutagenesis, aberration formation and DNA synthesis inhibition in V79 cells treated with N-methyl-N-nitrosourea or N-melhyl-N′-nitro-N-nitrosoguanidine. Mutat. Res., 142: 49-5, 1985.
54. Palitti, F., Tanzarella, C., Degrassi, F., De Salvia, K., Fiore, M., and Natarajan, A. T. Formation of chromatid-type aberrations in G2 stage of the cell cycle. Mutat. Res., 110: 343-350, 1983.
55. Hu, E., Mueller, E., Oliviero, S., Papaioannou, E., Johnson, R., and Spiegelman, B. M. Targeted disruption of the c-fos gene demonstrates c-fos-dependem and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J., 13: 3094-3103, 1994.
56. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclindependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-576, 1994.
57. Shivji, M. K. K., Kenny, M. K., and Wood, R. D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 69: 367-374, 1992.
58. Fornace, A. J., Jr., Zmudzka, B., Hollander, C., and Wilson, S. H. Induction of β-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol. Cell. Biol., 9: 851-853, 1989.
59. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
60. 6-methylguanine DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65: 506-512, 1996.
61. Sobol, R. W., Horton, J. K., Kühn, R., Gu, H., Singhai, R. K., Prasad, R., Rajewski, K., and Wilson, S. H. Requirement of mammalian DNA polymerase-β in baseexcision repair. Nature (Lond.), 379: 183-186, 1996.
62. Tew, K., Colvin, M., and Chabner, B. A. Alkylating agents. In: B. A. Chabner and D. L. Longo (eds.), Cancer Chemotherapy: Principles and Practice, 2nd Ed. Philadelphia: J. B. Lippincott Co., 1995.
63. Scanlon, K. J., Jiao, L., Funato, T., Wang, W., Tone, T., Rossi, J. J., and Kashani-Sabet, M. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl. Acad. Sci. USA, 88: 10591-10595, 1991.